he =ist of T.N.F. diseases is long," Tracey said. "So when =e created SetPoint" — the start-up he founded in 2007 with a physician and researcher at =assachusetts General Hospital in Boston — "we had to figure out what =e were going to treat." They wanted to start with an illness that could be mitigated by blocking =umor necro